AxoGen, Inc. AXGN
43.39
0.07
0.16%
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow AXGN
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(1.90%) | (13.49%) | (17.96%) | (18.21%) | |
| (1.03%) | (7.38%) | (12.95%) | (13.15%) | ||
ROIC |
1.68% | (3.25%) | (3.48%) | (4.99%) | |
Return on Tangible Assets |
(1.24%) | (8.79%) | (13.01%) | (13.29%) | |
Average Days of Receivables |
52.32 | 42.41 | 43.40 | 49.59 | |
Free Cash Flow per Share |
0.04 | (0.10) | 0.15 | 0.12 | |
Free Cash Flow |
2.06 | (4.78) | 7.66 | 6.51 | |
Capital Expenditures |
(4.45) | (5.59) | (7.90) | (8.54) | |
Piotroski F-Score |
6.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
2.88% | 0.34% | 4.22% | 3.88% | |
Accounts Receivable Turnover |
7.75 | 8.96 | 8.72 | 8.08 | |
Accounts Payable Turnover |
2.31 | 2.32 | 2.73 | 2.50 | |
Inventory Turnover |
1.55 | 1.53 | 1.46 | 1.52 | |
Average Days of Payables |
172.92 | 133.65 | 146.61 | 162.19 | |
Days of Inventory on Hand |
273.34 | 267.33 | 282.66 | 270.22 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.67% | 14.60% | 14.41% | 14.35% | |
Selling, General and Administrative Expense of Revenue |
60.25% | 63.19% | 64.39% | 65.32% | |
Share Based Compensation of Revenue |
7.72% | 13.37% | 14.30% | 14.99% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(3.10) | (0.05) | (0.49) | (0.45) | |
Depreciation/Fixed assets |
0.10 | 0.11 | 0.11 | 0.12 | |
Capex/Depreciation |
(0.53) | (0.60) | (0.83) | (0.89) | |
Revenue per Share |
4.62 | 4.89 | 4.62 | 4.71 | |
Operating CF per Share |
0.14 | 0.02 | 0.30 | 0.28 | |
Capex per Share |
(0.10) | (0.12) | (0.15) | (0.16) | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
(0.98%) | (6.97%) | (13.21%) | (13.36%) |
Columns are period end dates